RedHill Announces Additional U.S. Government Funding for Opaganib Nuclear Countermeasure Development
TEL AVIV - RedHill Biopharma Ltd. , a specialty biopharmaceutical company, today announced that opaganib[1] has been awarded a further $1.7 million in U.S. Government funding, via a Small Business...